Stocks · Health care · Pharmaceutical Preparations

PUMA BIOTECHNOLOGY, INC.

PBYI Clue Score62
United States Fiscal year ends December CIK 0001401667 Results filed 5 Nov 2026

What the insiders did Mostly scheduled

Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$2.12M
$1.45M on a plan · $566.99K straight out of an exercise
Sold at will
$97.23K
1 of 17 sales
Net
−$2.12M
−$97.23K against sales at will